INTERNATIONAL PATENT: YIKANG BIOPHARMACEUTICALS CO., LTD, 易康生物（苏州）有限公司 FILES APPLICATION FOR "IMPROVED RESPIRATORY SYNCYTIAL VIRUS FUSION F PROTEIN MUTANT AND USE THEREOF"

GENEVA, June 29 -- YIKANG BIOPHARMACEUTICALS CO., LTD (4F Building C19, BioBAY, 218 Xinghu Str., Suzhou Industrial ParkSuzhou, Jiangsu 215000), 易康生物（苏州）有限公司 (中国江苏省苏州市苏州工业园区星湖街218号生物医药产业园C19楼401单元) filed a patent application (PCT/CN2024/087839) for "IMPROVED RESPIRATORY SYNCYTIAL VIRUS FUSION F PROTEIN MUTANT AND USE THEREOF" on Apr 15, 2024. With publication no. WO/2025/129864, the details related to the patent application was published on Jun 26, 2025.

Notably, th...